Friday, March 14, 2008

Another Canadian Link for Indy

According to Inside INdiana Business, Indianapolis-based Eli Lilly and Co. has reached a licensing and collaboration agreement with Transition Therapeutics Inc. The Canadian company specializes in an emerging class of potential disease-modifying therapies for diabetes patients. The agreement gives Lilly exclusive worldwide rights to develop and commercialize the therapies.

No comments: